Companies › MTNB
MATINAS BIOPHARMA HLDGS INC (MTNB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001582554 · EDGAR filings · Updated 2026-07-24
MATINAS BIOPHARMA HLDGS INC (MTNB) has reported institutional ownership of 5.5%, with 28 institutional managers holding positions valued at $177.3K per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-24 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-21 — 425 filed
- 2026-07-16 — 425 filed
- 2026-07-14 — SCHEDULE 13G filed
- 2026-07-13 — 425 filed
- 2026-07-13 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, MATINAS BIOPHARMA HLDGS INC has 28 institutional holders and institutional ownership of 5.5%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
VYOME HOLDINGS INC (HIND) · Biorestorative Therapies Inc (BRTX) · ENvue Medical Inc (FEED) · XTL BIOPHARMACEUTICALS LTD (XTLB) · Genprex Inc (GNPX) · CURANEX PHARMACEUTICALS INC (CURX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.